Dive Brief:
- Claris Lifesciences, based in Ahmedabad, focuses on generic sterile injectables ---an area where demand currently outweighs supply.
- Part of the interest in Claris is fueled by Pfizer's recent $17 billion acquisition of Hospira.
- Injectables are drugs that are used through vials, syringes and bags. Pumps are used to deliver the medications.
Dive Insight:
Who's bidding? The short list includesLupin, Cipla, Zydus Cadilla and Pfizer. There is also a strong possibility that Dr. Reddy's, Sun Pharma and Novartis are also bidding. This could be the beginning of an M&A trend.